[1
]
From Cardiovascular Performance Program, Massachusetts General Hospital, Boston (A.L.B.);
Division of Heart Rhythm Services, Department of Cardiovascular Diseases, and Division
of Pediatric Cardiology, Department of Pediatrics, and Windland Smith Rice Sudden
Death Genomics Laboratory, Department of Molecular Pharmacology and Experimental Therapeutics,
Mayo Clinic, Rochester, MN (M.J.A.); and Cardiology/Internal Medicine, Yale School
of Medicine, New Haven, CT (R.L.). abaggish@partners.org.
[2
]
From Cardiovascular Performance Program, Massachusetts General Hospital, Boston (A.L.B.);
Division of Heart Rhythm Services, Department of Cardiovascular Diseases, and Division
of Pediatric Cardiology, Department of Pediatrics, and Windland Smith Rice Sudden
Death Genomics Laboratory, Department of Molecular Pharmacology and Experimental Therapeutics,
Mayo Clinic, Rochester, MN (M.J.A.); and Cardiology/Internal Medicine, Yale School
of Medicine, New Haven, CT (R.L.).
